Guidelines for clinical trials using artificial intelligence – SPIRIT‐AI and CONSORT‐AI †
The Journal of Pathology2020Vol. 253(1), pp. 14–16
Citations Over TimeTop 17% of 2020 papers
Abstract
The rapidly growing use of artificial intelligence in pathology presents a challenge in terms of study reporting and methodology. The existing guidelines for the design (SPIRIT) and reporting (CONSORT) of clinical trials have been extended with the aim of ensuring production of the highest quality evidence in this field. We explore these new guidelines and their relevance and application to pathology as a specialty. © 2020 The Authors. The Journal of Pathology published by John Wiley & Sons, Ltd. on behalf of The Pathological Society of Great Britain and Ireland.
Related Papers
- → Adoption of CONSORT Statements for Randomized Control Trials Published in the Journal of Pediatric Nursing(2011)5 cited
- → An Analysis of the US News & World Report Methodology for Attribution of Specialty Care in Otolaryngology and Urology(2020)7 cited
- → Migration of Physicians From One Specialty to Another(1978)23 cited
- → CONSORT for Nonpharmacologic Treatments(2014)3 cited
- Research on Optimization of the Specialty Structure of Higher Vocational Education in Shanxi(2006)